Noribogaine Generalization to the Ibogaine Stimulus: Correlation with Noribogaine Concentration in Rat Brain

[1]  J. C. Winter,et al.  Behavioral and Biochemical Evidence for a Nonessential 5-HT2A Component of the Ibogaine-Induced Discriminative Stimulus , 1998, Pharmacology Biochemistry and Behavior.

[2]  J. C. Winter,et al.  The Effects of Sigma, PCP, and Opiate Receptor Ligands in Rats Trained With Ibogaine as a Discriminative Stimulus , 1998, Pharmacology Biochemistry and Behavior.

[3]  H. Jones,et al.  Failure of Ibogaine to Produce Phencyclidine-Like Discriminative Stimulus Effects in Rats and Monkeys , 1998, Pharmacology Biochemistry and Behavior.

[4]  Ying-Jun Cao,et al.  Effects of noribogaine on the development of tolerance to antinociceptive action of morphine in mice , 1997, Brain Research.

[5]  S. D. Glick,et al.  Time-dependent interactions between iboga agents and cocaine. , 1997, European journal of pharmacology.

[6]  J. C. Winter,et al.  The effects of noribogaine and harmaline in rats trained with ibogaine as a discriminative stimulus. , 1997, Life sciences.

[7]  Martin D. Schechte.  Serotonergic mediation of fenfluramine discriminative stimuli in fawn-hooded rats. , 1997 .

[8]  L. Farde,et al.  The relevance of serotonergic mechanisms in the treatment of schizophrenia has not been confirmed , 1997, Journal of psychopharmacology.

[9]  A. Scallet,et al.  NOS and fos in Rat and Mouse Brain Regions , 1996, Annals of the New York Academy of Sciences.

[10]  S. D. Glick,et al.  18-Methoxycoronaridine, a non-toxic iboga alkaloid congener: effects on morphine and cocaine self-administration and on mesolimbic dopamine release in rats , 1996, Brain Research.

[11]  S. D. Glick,et al.  Ibogaine-like effects of noribogaine in rats , 1996, Brain Research.

[12]  A. Jeffcoat,et al.  Determination of ibogaine in plasma by gas chromatography--chemical ionization mass spectrometry. , 1996, Journal of chromatography. A.

[13]  S. D. Glick,et al.  Tissue distribution of ibogaine after intraperitoneal and subcutaneous administration. , 1996, Life sciences.

[14]  J. Witkin,et al.  Discriminative stimulus effects of R-(+)-3-amino-1-hydroxypyrrolid-2-one, [(+)-HA-966], a partial agonist of the strychnine-insensitive modulatory site of the N-methyl-D-aspartate receptor. , 1995, The Journal of pharmacology and experimental therapeutics.

[15]  P. Skolnick,et al.  NMDA antagonist properties of the putative antiaddictive drug, ibogaine. , 1995, The Journal of pharmacology and experimental therapeutics.

[16]  W. Hearn,et al.  Identification and quantitation of ibogaine and an o-demethylated metabolite in brain and biological fluids using gas chromatography-mass spectrometry. , 1995, Journal of analytical toxicology.

[17]  D. Mash,et al.  Identification of a primary metabolite of ibogaine that targets serotonin transporters and elevates serotonin. , 1995, Life sciences.

[18]  R. A. Davidoff,et al.  Properties of ibogaine and its principal metabolite (12-hydroxyibogamine) at the MK-801 binding site of the NMDA receptor complex , 1995, Neuroscience Letters.

[19]  Siming Li,et al.  Expression and localization of inhibin α-subunit in rat retinal photoreceptor cells , 1995 .

[20]  S. D. Glick,et al.  Radioligand-binding study of noribogaine, a likely metabolite of ibogaine , 1995, Brain Research.

[21]  S. G. Sheppard.  A preliminary investigation of ibogaine: case reports and recommendations for further study. , 1994, Journal of substance abuse treatment.

[22]  T. L. Gordon,et al.  Comparison of the behavioral effects of ibogaine from three sources: mediation of discriminative activity. , 1993, European journal of pharmacology.

[23]  S. Cappendijk,et al.  Inhibitory effects of ibogaine on cocaine self-administration in rats. , 1993, European journal of pharmacology.

[24]  J. C. Winter,et al.  Stimulus effects of ibogaine in rats trained with yohimbine, DOM, or LSD , 1992, Pharmacology Biochemistry and Behavior.

[25]  S. D. Glick,et al.  Mechanisms of action of ibogaine and harmaline congeners based on radioligand binding studies , 1992, Brain Research.

[26]  S. D. Glick,et al.  Interactions between ibogaine, a potential anti-addictive agent, and morphine: an in vivo microdialysis study. , 1991, European journal of pharmacology.

[27]  D. Sanger,et al.  The discriminative stimulus effects of MK-801: Generalization to other N-methyl-D-aspartate receptor antagonists , 1989, Journal of psychopharmacology.

[28]  G. Zetler,et al.  Cerebral pharmacokinetics of tremor-producing harmala and iboga alkaloids. , 1972, Pharmacology.